Skip to main content
Home
Company
About Passage Bio
Leadership Team
Board of Directors
Management Team
Science & Technology
Our GTP Partnership
Vector Selection and Delivery
Manufacturing
Pipeline
Pipeline Chart
GM1 Gangliosidosis & Imagine-1
Frontotemporal Dementia
Krabbe Disease
Discovery Programs
Patients and Families
Patient Resources
Rare Disease Facts
Natural History Study
Investors & Media
Overview
News & Events
Press Release
Events & Presentations
Stock Information
Stock Quote & Chart
Financials & Filings
SEC Filings
Corporate Governance
Documents & Charters
Leadership Team
Board of Directors
Investor Resources
Investor FAQs
Investor Contact
Email Alerts
Careers
Contact
Pipeline Chart
Home
Company
About Passage Bio
Leadership Team
Board of Directors
Management Team
Science & Technology
Our GTP Partnership
Vector Selection and Delivery
Manufacturing
Pipeline
Pipeline Chart
GM1 Gangliosidosis & Imagine-1
Frontotemporal Dementia
Krabbe Disease
Discovery Programs
Patients and Families
Patient Resources
Rare Disease Facts
Natural History Study
Investors & Media
Overview
News & Events
Stock Information
Financials & Filings
Corporate Governance
Investor Resources
Careers
Contact
Pipeline Chart
A Broad and Robust Pipeline with Global Rights
Multiple potential value creating catalysts in 2021
GM1 Gangliosidosis
Frontotemporal Dementia (FTD)
Krabbe Disease